| Jul 28 |
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
|
| Jul 27 |
Is Viking Therapeutics a Millionaire-Maker Stock?
|
| Jul 26 |
June PCE inflation print, auto earnings: Morning Brief
|
| Jul 26 |
Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon
|
| Jul 26 |
Eli Lilly loses $120B in value over Viking's GLP-1 progress
|
| Jul 25 |
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
|
| Jul 25 |
Why Viking’s Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks
|
| Jul 25 |
Viking Therapeutics weight-loss drug moves to Phase 3 trial
|
| Jul 25 |
Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
|
| Jul 25 |
Viking Therapeutics: Better-Than-Expected Trial Timelines While Pipeline Expands
|
